Bill
S 5433
Bill S 5433 allows pharmacists to test for certain infectious diseases, improving access to testing and early diagnosis, benefiting patients and public health efforts.
Bill Number: S 5433
Title: Relates to allowing for the testing of certain infectious diseases by pharmacists
Status: Referred to Health
Introduced: February 21, 2025
Classification: Bill
Bill S 5433 aims to expand the role of pharmacists in public health by permitting them to conduct tests for specific infectious diseases. This initiative is intended to enhance access to testing, improve early detection of diseases, and ultimately contribute to better health outcomes for the community.
Testing Authorization: The bill authorizes licensed pharmacists to perform tests for designated infectious diseases. The specific diseases that may be included will be determined by health authorities and specified in the bill's final text.
Training Requirements: Pharmacists will be required to undergo specific training to ensure they are qualified to conduct these tests safely and effectively. This training will cover the proper procedures for testing, interpretation of results, and patient counseling.
Reporting Obligations: Pharmacists who conduct tests will be mandated to report results to appropriate health authorities to ensure proper tracking of infectious disease prevalence and to facilitate public health responses.
Patient Education: The bill emphasizes the importance of patient education, requiring pharmacists to provide information about the tests, potential results, and next steps for care.
Pharmacists: This bill directly impacts pharmacists by expanding their scope of practice and providing them with new responsibilities in disease management.
Patients: Individuals seeking testing for infectious diseases will benefit from increased access to testing services, potentially leading to earlier diagnosis and treatment.
Public Health Authorities: The bill will affect public health agencies by increasing the volume of data collected on infectious diseases, which can inform public health strategies and resource allocation.
Current Status: As of February 21, 2025, the bill has been referred to the Health Committee for further consideration.
Related Legislation: This bill is related to prior-session bills S 8570, S 1742, and S 5263, which may have addressed similar issues or laid the groundwork for this legislation.
Bill S 5433 represents a significant step toward enhancing the role of pharmacists in public health by allowing them to conduct tests for infectious diseases. By improving access to testing and fostering early detection, the bill aims to contribute positively to community health outcomes. The next steps will involve committee discussions and potential amendments before further legislative action.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
